# AZD1305 Single and Multiple Ascending Dose Study in Healthy Japanese and Caucasian Subjects

> **NCT00935025** · PHASE1 · TERMINATED · sponsor: **AstraZeneca** · enrollment: 45 (estimated)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** AZD1305
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00935025
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-07
- **Primary completion:** 2009-11
- **Final completion:** 2009-11
- **Target enrollment:** 45 (ESTIMATED)
- **Last updated:** 2010-12-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00935025

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00935025, "AZD1305 Single and Multiple Ascending Dose Study in Healthy Japanese and Caucasian Subjects". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT00935025. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*